Literature DB >> 20544928

Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis.

Rosa Rademakers1, Heather Stewart, Mariely Dejesus-Hernandez, Charles Krieger, Neill Graff-Radford, Marife Fabros, Hannah Briemberg, Neil Cashman, Andrew Eisen, Ian R A Mackenzie.   

Abstract

Mutations in the fused in sarcoma (FUS) gene have recently been found to cause familial amyotrophic lateral sclerosis (FALS). We screened FUS in a cohort of 200 ALS patients [32 FALS and 168 sporadic ALS (SALS)]. In one FALS proband, we identified a mutation (p.R521C) that was also present in her affected daughter. Their clinical phenotype was remarkably similar and atypical of classic ALS, with symmetric proximal pelvic and pectoral weakness. Distal weakness and upper motor neuron features only developed late. Neuropathological examination demonstrated FUS-immunoreactive neuronal and glial inclusions in the spinal cord and many extramotor regions, but no TDP-43 pathology. We also identified a novel mutation (p.G187S) in one SALS patient. Overall, FUS mutations accounted for 3% of our non-SOD1, non-TARDBP FALS cases and 0.6% of SALS. This study demonstrates that the phenotype with FUS mutations extends beyond classical ALS cases. Our findings suggest there are specific clinicogenetic correlations and provide the first detailed neuropathological description.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544928      PMCID: PMC2969843          DOI: 10.1002/mus.21665

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  30 in total

1.  Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation.

Authors:  Adriano Chiò; Gabriella Restagno; Maura Brunetti; Irene Ossola; Andrea Calvo; Gabriele Mora; Mario Sabatelli; Maria Rosaria Monsurrò; Stefania Battistini; Jessica Mandrioli; Fabrizio Salvi; Rossella Spataro; Jennifer Schymick; Bryan J Traynor; Vincenzo La Bella
Journal:  Neurobiol Aging       Date:  2009-05-17       Impact factor: 4.673

2.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

Review 3.  Recent advances in the genetics of amyotrophic lateral sclerosis.

Authors:  Paul N Valdmanis; Hussein Daoud; Patrick A Dion; Guy A Rouleau
Journal:  Curr Neurol Neurosci Rep       Date:  2009-05       Impact factor: 5.081

4.  A new subtype of frontotemporal lobar degeneration with FUS pathology.

Authors:  Manuela Neumann; Rosa Rademakers; Sigrun Roeber; Matt Baker; Hans A Kretzschmar; Ian R A Mackenzie
Journal:  Brain       Date:  2009-08-11       Impact factor: 13.501

5.  Mutations in FUS cause FALS and SALS in French and French Canadian populations.

Authors:  V V Belzil; P N Valdmanis; P A Dion; H Daoud; E Kabashi; A Noreau; J Gauthier; P Hince; A Desjarlais; J-P Bouchard; L Lacomblez; F Salachas; P-F Pradat; W Camu; V Meininger; N Dupré; G A Rouleau
Journal:  Neurology       Date:  2009-09-09       Impact factor: 9.910

6.  Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort.

Authors:  N Ticozzi; V Silani; A L LeClerc; P Keagle; C Gellera; A Ratti; F Taroni; T J Kwiatkowski; D M McKenna-Yasek; P C Sapp; R H Brown; J E Landers
Journal:  Neurology       Date:  2009-09-09       Impact factor: 9.910

7.  Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.

Authors:  T J Kwiatkowski; D A Bosco; A L Leclerc; E Tamrazian; C R Vanderburg; C Russ; A Davis; J Gilchrist; E J Kasarskis; T Munsat; P Valdmanis; G A Rouleau; B A Hosler; P Cortelli; P J de Jong; Y Yoshinaga; J L Haines; M A Pericak-Vance; J Yan; N Ticozzi; T Siddique; D McKenna-Yasek; P C Sapp; H R Horvitz; J E Landers; R H Brown
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728

Review 8.  Rethinking ALS: the FUS about TDP-43.

Authors:  Clotilde Lagier-Tourenne; Don W Cleveland
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

9.  The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.

Authors:  Mattias K Andersson; Anders Ståhlberg; Yvonne Arvidsson; Anita Olofsson; Henrik Semb; Göran Stenman; Ola Nilsson; Pierre Aman
Journal:  BMC Cell Biol       Date:  2008-07-11       Impact factor: 4.241

10.  Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.

Authors:  Caroline Vance; Boris Rogelj; Tibor Hortobágyi; Kurt J De Vos; Agnes Lumi Nishimura; Jemeen Sreedharan; Xun Hu; Bradley Smith; Deborah Ruddy; Paul Wright; Jeban Ganesalingam; Kelly L Williams; Vineeta Tripathi; Safa Al-Saraj; Ammar Al-Chalabi; P Nigel Leigh; Ian P Blair; Garth Nicholson; Jackie de Belleroche; Jean-Marc Gallo; Christopher C Miller; Christopher E Shaw
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728

View more
  43 in total

1.  De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis.

Authors:  Mariely DeJesus-Hernandez; Jannet Kocerha; NiCole Finch; Richard Crook; Matt Baker; Pamela Desaro; Amelia Johnston; Nicola Rutherford; Aleksandra Wojtas; Kathleen Kennelly; Zbigniew K Wszolek; Neill Graff-Radford; Kevin Boylan; Rosa Rademakers
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

2.  Combined FDG and raclopride PET study in a case of ALS with the R521C FUS gene mutation.

Authors:  Satoshi Kono; Yasuomi Ouchi; Tatsuhiro Terada; Makiko Suzuki; Shunsuke Yagi; Hiroaki Miyajima
Journal:  J Neurol       Date:  2011-07-15       Impact factor: 4.849

3.  Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.

Authors:  Ian R A Mackenzie; Olaf Ansorge; Michael Strong; Juan Bilbao; Lorne Zinman; Lee-Cyn Ang; Matt Baker; Heather Stewart; Andrew Eisen; Rosa Rademakers; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2011-05-21       Impact factor: 17.088

Review 4.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

Review 5.  The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.

Authors:  Oliver D King; Aaron D Gitler; James Shorter
Journal:  Brain Res       Date:  2012-01-21       Impact factor: 3.252

Review 6.  The role of FUS gene variants in neurodegenerative diseases.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

Review 7.  Fused in Sarcoma Neuropathology in Neurodegenerative Disease.

Authors:  Ian R A Mackenzie; Manuela Neumann
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 8.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

Review 9.  Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.

Authors:  Ian R A Mackenzie; Manuela Neumann; Nigel J Cairns; David G Munoz; Adrian M Isaacs
Journal:  J Mol Neurosci       Date:  2011-05-21       Impact factor: 3.444

Review 10.  EWSR1, a multifunctional protein, regulates cellular function and aging via genetic and epigenetic pathways.

Authors:  Junghee Lee; Phuong T Nguyen; Hyun Soo Shim; Seung Jae Hyeon; Hyeonjoo Im; Mi-Hyun Choi; Sooyoung Chung; Neil W Kowall; Sean Bong Lee; Hoon Ryu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-11-24       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.